Bonus Biogroup Stock Market Value
| BBIXF Stock | USD 0.04 0.01 75.00% |
| Symbol | Bonus |
Bonus BioGroup 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Bonus BioGroup's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Bonus BioGroup.
| 01/02/2025 |
| 02/01/2025 |
If you would invest 0.00 in Bonus BioGroup on January 2, 2025 and sell it all today you would earn a total of 0.00 from holding Bonus BioGroup or generate 0.0% return on investment in Bonus BioGroup over 30 days. Bonus BioGroup is related to or competes with Covalon Technologies, Mosaic Immunoengineerin, and Cellectis. Bonus BioGroup Ltd., a biotechnology company, develops technology solutions to generate tissue-regenerating bone grafts More
Bonus BioGroup Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Bonus BioGroup's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Bonus BioGroup upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.1146 | |||
| Maximum Drawdown | 75.0 |
Bonus BioGroup Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bonus BioGroup's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Bonus BioGroup's standard deviation. In reality, there are many statistical measures that can use Bonus BioGroup historical prices to predict the future Bonus BioGroup's volatility.| Risk Adjusted Performance | 0.1123 | |||
| Jensen Alpha | 1.06 | |||
| Total Risk Alpha | 0.3704 | |||
| Treynor Ratio | 1.2 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bonus BioGroup's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Bonus BioGroup Backtested Returns
Bonus BioGroup is out of control given 3 months investment horizon. Bonus BioGroup secures Sharpe Ratio (or Efficiency) of 0.13, which signifies that the company had a 0.13 % return per unit of risk over the last 3 months. We have analyzed and interpolated nineteen different technical indicators, which can help you to evaluate if expected returns of 1.19% are justified by taking the suggested risk. Use Bonus BioGroup Standard Deviation of 9.23, risk adjusted performance of 0.1123, and Mean Deviation of 2.24 to evaluate company specific risk that cannot be diversified away. Bonus BioGroup holds a performance score of 9 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 0.94, which signifies possible diversification benefits within a given portfolio. Bonus BioGroup returns are very sensitive to returns on the market. As the market goes up or down, Bonus BioGroup is expected to follow. Use Bonus BioGroup variance, skewness, as well as the relationship between the Skewness and day median price , to analyze future returns on Bonus BioGroup.
Auto-correlation | 0.00 |
No correlation between past and present
Bonus BioGroup has no correlation between past and present. Overlapping area represents the amount of predictability between Bonus BioGroup time series from 2nd of January 2025 to 17th of January 2025 and 17th of January 2025 to 1st of February 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Bonus BioGroup price movement. The serial correlation of 0.0 indicates that just 0.0% of current Bonus BioGroup price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Bonus BioGroup lagged returns against current returns
Autocorrelation, which is Bonus BioGroup pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Bonus BioGroup's pink sheet expected returns. We can calculate the autocorrelation of Bonus BioGroup returns to help us make a trade decision. For example, suppose you find that Bonus BioGroup has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Bonus BioGroup regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Bonus BioGroup pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Bonus BioGroup pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Bonus BioGroup pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Bonus BioGroup Lagged Returns
When evaluating Bonus BioGroup's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Bonus BioGroup pink sheet have on its future price. Bonus BioGroup autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Bonus BioGroup autocorrelation shows the relationship between Bonus BioGroup pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Bonus BioGroup.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
| EBR | Centrais Electricas Brasileiras | |
| HE | Hawaiian Electric Industries | |
| VFC | VF Corporation | |
| BVHMF | Vistry Group PLC | |
| S | SentinelOne |
Other Information on Investing in Bonus Pink Sheet
Bonus BioGroup financial ratios help investors to determine whether Bonus Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bonus with respect to the benefits of owning Bonus BioGroup security.